Rafael Holdings Q1 fiscal 2024 net loss narrows to $3.8M from $5.2M YoY

Rafael Holdings, Inc.

2024-Q1 EPS reported -$0.16 revenue$68,000

Net loss from continuing operations of $3.8M ($0.15/share) vs $5.2M ($0.22/share) a year ago.
Cash, cash equivalents and marketable securities of $72.1M as of Oct 31, 2023.
R&D expenses fell to $0.5M from $2.1M, driven by winding down early-stage programs.
G&A expenses decreased to $2.0M from $3.1M due to lower stock-based compensation and payroll.
CEO says company advancing portfolio and seeking strategic investments; continues supporting Cyclo Therapeutics (CYTH).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Rafael Holdings, Inc. reported first quarter of fiscal 2024 - the three months ended October 31, 2023 results: net income net loss from continuing operations of $3.8 million, or $0.15 per share, EPS $0.15 per share.

Period: first quarter of fiscal 2024 - the three months ended October 31, 2023
Net income: net loss from continuing operations of $3.8 million, or $0.15 per share
EPS: $0.15 per share
Result: reported results

Exact text from the filing

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

View on SEC.gov

308 earnings releases filed in the last 30 days. Browse all earnings releases →

Rafael Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-095718

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.